PRESS RELEASE published on 04/25/2025 at 07:15, 8 months 6 days ago Acquisition or disposal of the issuer's own shares / Description of the buyback program Eurofins launches sixth buy-back programme of its own shares with plans to repurchase up to 4.5% of share capital. Programme starting on 25 April 2025 aims to hedge Long-Term Incentive plans and support other financial initiatives Share Capital Financial Services Buy-back Programme Eurofins ISIN FR0014000MR3
PRESS RELEASE published on 04/25/2025 at 07:01, 8 months 6 days ago PALFINGER aims for 2025 to be the second strongest financial year in the company's history PALFINGER AG aims for 2025 to be the second strongest financial year in the company's history, with positive order intake and global development Revenue Growth Financial Year Order Intake PALFINGER AG Global Development
PRESS RELEASE published on 04/25/2025 at 07:00, 8 months 6 days ago Xlife Sciences AG publishes 2024 Annual Report: Strategic Expansion, Technological Milestones, and International Capital Market Presence Xlife Sciences AG publishes 2024 Annual Report highlighting strategic partnerships, technological milestones, and dual listing plans on SIX and LSE to enhance international market presence Strategic Partnerships Dual Listing Xlife Sciences AG 2024 Annual Report Technological Milestones
PRESS RELEASE published on 04/25/2025 at 07:00, 8 months 6 days ago Swiss Life publishes financial condition report – solvency remains strong Swiss Life publishes financial condition report with strong solvency position, exceeding strategic ambition range. Detailed information available at www.swisslife.com/results Swiss Life Swiss Life Group Financial Condition Report Solvency 2024 Annual Report
PRESS RELEASE published on 04/25/2025 at 07:00, 8 months 6 days ago EQS-Adhoc: BB Biotech AG publishes its interim report BB Biotech AG publishes its interim report covering the first three months of 2025 revealing a net loss of CHF 241 mn. More information at report.bbbiotech.ch/Q125 Financial Results Investment Company BB Biotech AG Interim Report Business Activities
PRESS RELEASE published on 04/25/2025 at 07:00, 8 months 6 days ago Blue Cap AG: Major shareholder PartnerFonds creates basis for further progress in the realization of the Blue Cap share package PartnerFonds AG i.L. plans share exchange offer with Blue Cap AG at fair value, progressing liquidation process. Stable shareholder base confirmed by anchor investors Blue Cap AG Liquidation Process Share Exchange Offer PartnerFonds AG Anchor Investors
PRESS RELEASE published on 04/25/2025 at 07:00, 8 months 6 days ago ATOSS Software SE: Successful start to the year in the first quarter of 2025 with continuous double-digit growth ATOSS Software SE reports successful first quarter results for 2025 with 11% revenue growth driven by cloud and subscription services. Management forecasts around EUR 190 million revenue for 2025 Revenue Growth Cloud Services First Quarter ATOSS Software SE 2025 Forecast
PRESS RELEASE published on 04/25/2025 at 07:00, 8 months 6 days ago BB Biotech Q1 2025: Sharpened portfolio focus amid continued market volatility BB Biotech AG reports net loss in Q1 2025 due to market volatility. Portfolio focus on innovative biotech companies above USD 1 bn. Details on exits and regulatory milestones Market Volatility BB Biotech AG Biotech Companies Q1 2025 Portfolio Focus
PRESS RELEASE published on 04/25/2025 at 07:00, 8 months 6 days ago SoftwareOne publishes agenda for ordinary Annual General Meeting SoftwareOne Holding AG publishes agenda for ordinary Annual General Meeting with proposals for dividend approval and new Chairman election. Meeting to be held on 16 May 2025 in Lucerne Annual General Meeting Dividend Switzerland SoftwareOne Chairman Election
PRESS RELEASE published on 04/25/2025 at 07:00, 8 months 6 days ago Nordex Group enters 2025 on a strong footing with improved margins, positive free cash flow and confirmation of full year guidance Nordex Group posts solid financial performance in Q1 2025 with improved margins and positive free cash flow, aiming to achieve full year targets Financial Performance EBITDA Margin Free Cash Flow Nordex Group Q1 2025
Published on 12/31/2025 at 22:30, 42 minutes ago ROK Resources Receives Final Order and Enters into Amending Agreement to Extend Outside Date
Published on 12/31/2025 at 21:00, 2 hours 12 minutes ago 55 North Mining Appoints Wayne Parsons as Executive Chair; Strengthens Leadership as the Company Advances the Last Hope Gold Project
Published on 12/31/2025 at 20:00, 3 hours 12 minutes ago Pathfinder Responds to Recent Market Activity
Published on 12/31/2025 at 18:15, 4 hours 57 minutes ago CoTec Investment MagIron Completes Purchase of Reynolds Pellet Plant
Published on 12/31/2025 at 18:00, 5 hours 12 minutes ago IBC Advanced Alloys Announces Amendment of Existing Credit Facilities
Published on 12/31/2025 at 17:45, 5 hours 27 minutes ago FIGEAC AÉRO: PUBLICATION OF THE HALF-YEAR FINANCIAL REPORT 2025/26
Published on 12/31/2025 at 16:23, 6 hours 49 minutes ago Form 8.3 - The Vanguard Group, Inc.: Unite Group plc, The
Published on 12/31/2025 at 16:22, 6 hours 50 minutes ago Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc.
Published on 12/31/2025 at 16:22, 6 hours 50 minutes ago Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc
Published on 12/29/2025 at 18:05, 2 days 5 hours ago Covivio - Treasury shares transactions between December 22nd , 2025 and December 24th, 2025
Published on 12/29/2025 at 17:35, 2 days 5 hours ago Disclosure of transactions in own shares from December 22 to December 24, 2025
Published on 12/22/2025 at 18:05, 9 days 5 hours ago Covivio - Treasury shares transactions between December 15th , 2025 and December 19th, 2025
Published on 12/22/2025 at 17:35, 9 days 5 hours ago DISCLOSURE OF TRANSACTIONS IN OWN SHARES FROM DECEMBER 15 TO DECEMBER 19, 2025